Position in ALNY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$2,794,762
+$1,181,440 QoQ
Shares Held
9,284
+90.4% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#290
of 784 holders
Holding Since
Mar 2025
3 quarters on record
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Saudi Central Bank holds $22,821,239 across 7 Biotechnology names. ALNY ranks #3 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,805 | $8,844,277 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,273 | $4,535,006 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
9,284 | $2,794,762 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
11,324 | $2,120,758 | |
| 5 | RPRX |
Royalty Pharma plc
|
28,773 | $1,613,302 | |
| 6 | INSM |
INSMED Inc
|
14,732 | $1,570,725 | |
| 7 | INCY |
Incyte Corp
|
11,842 | $1,342,409 |
All Filings in ALNY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,794,762 | 9,284 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,613,322 | 4,876 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $13,771 | 51 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||